Insider Stock Trading History of Denner Alexander J


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Denner Alexander J since year 2005. The trader's CIK number is 1361754. At the time of this reporting, Denner Alexander J is the Director of Biogen Inc. . (stock ticker symbol BIIB). See this page for all insider trading activities at Biogen Inc. .

Note that in the past DENNER ALEXANDER J also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Denner Alexander J since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-11-28 BIIB Biogen Inc. Buy 20,000 316.12 6,322,400
2017-11-29 BIIB Biogen Inc. Buy 10,000 319.84 3,198,399
2017-11-29 MDCO Medicines Co /de Buy 170,000 30.03 5,105,100
2017-05-30 BIVV Bioverativ Inc. Buy 90,000 55.93 5,033,520
2017-05-24 BIVV Bioverativ Inc. Buy 340,000 54.16 18,414,400
2017-05-26 BIVV Bioverativ Inc. Buy 450,000 57.21 25,744,950
2017-05-25 BIVV Bioverativ Inc. Buy 130,000 54.98 7,147,920
2017-04-27 BIIB Biogen Inc. Buy 73,858 278.53 20,571,668
2015-10-22 BIIB Biogen Inc. Buy 210,000 277.80 58,338,000
2015-10-23 BIIB Biogen Inc. Buy 100,000 276.77 27,677,000
2014-08-15 ARIA Ariad Pharmaceuticals Inc Buy 850,000 5.83 4,955,500
2013-11-08 VVUS Vivus Inc Buy 417,068 8.52 3,553,419
2013-11-11 VVUS Vivus Inc Buy 149,776 8.78 1,315,033
2013-06-14 BIIB Biogen Inc. Sale 2,900 212.00 614,800
2013-05-29 BIIB Biogen Inc. Option Ex 3,000 53.43 160,290
2013-05-28 BIIB Biogen Inc. Sale 37,975 239.77 9,105,113
2013-05-28 BIIB Biogen Inc. Option Ex 37,975 53.43 2,029,004
2012-12-26 BIIB Biogen Inc. Sale 3,989 148.89 593,914
2012-12-27 BIIB Biogen Inc. Sale 3,991 148.53 592,799
2012-01-17 AMLN Amylin Pharmaceuticals Inc Option Ex 5,993 .00 0
2012-01-17 AMLN Amylin Pharmaceuticals Inc Sale 1,832 11.59 21,232

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Denner Alexander J (Director of Biogen Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.